Doribax

Active Ingredient(s): Doripenem
FDA Approved: * October 12, 2007
Pharm Company: * JOHNSON AND JOHNSON
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Doribax Overview

Doripenem is an ultra-broad-spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa. The usual form is doripenem monohydrate. Doripenem can be used for bacterial infections such as: complex abdominal infections, pneumonia within the setting of a hospital, and ...

Read more Doribax Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doripenem

Recent Doribax Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Doripenem
  • Injection: 250mg/vial, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Doribax: (4 results)

Sorted by National Drug Code
  • 50458-401 Doribax 500 mg/10ml Intravenous Powder, for Solution by Janssen Pharmaceuticals, Inc.
  • 50458-402 Doribax 250 mg/10ml Intravenous Powder, for Solution by Janssen Pharmaceuticals, Inc.
  • 59630-309 Doribax 250 mg/10ml Intravenous Powder, for Solution by Shionogi Inc.
  • 59630-320 Doribax 500 mg/10ml Intravenous Powder, for Solution by Shionogi Inc.

Other drugs which contain Doripenem or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA